The goal of this observational study is to learn about the Asqelio monofocal intraocular lens (IOL) model QLIO130C in patients undergoing cataract surgery. The aim of the study is to evaluate the lens implementation safety and efficacy after at least 24 months.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Incidence of Posterior capsular opacity
Timeframe: 24 months after IOL implantation
Intensity of Posterior capsular opacity
Timeframe: 24 months after IOL implantation
Visual acuity
Timeframe: At least 24 months after IOL implantation